Skip to content

Adrenal Tumors - Pathogenesis and Therapy

Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00669266
Enrollment
500
Registered
2008-04-30
Start date
2002-09-01
Completion date
2032-12-01
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Tumors, Adrenocortical Carcinoma, Conn Syndrome, Cushing Syndrome, Pheochromocytoma

Brief summary

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Interventions

None listed

Sponsors

University of Wuerzburg
Lead SponsorOTHER
Deutsche Krebshilfe e.V., Bonn (Germany)
CollaboratorOTHER
German Federal Ministry of Education and Research
CollaboratorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
No

Inclusion criteria

* adrenal tumor detected by imaging

Countries

Germany

Contacts

CONTACTMartin Fassnacht, MD
fassnacht_m@medizin.uni-wuerzburg.de49-931-201-36507
PRINCIPAL_INVESTIGATORMartin Fassnacht, MD

U of Wuerzburg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026